Ovarian Epithelial Cancer Recurrent Clinical Trial
Official title:
Multicenter and Retrospective Observational Study to Analyze the Efficacy and Safety of the Combination With Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to Data Sheet
Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01899599 -
PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01715168 -
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
|
Phase 1 | |
| Completed |
NCT01588964 -
IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer
|
Phase 2 | |
| Completed |
NCT02026921 -
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
|
Phase 2 | |
| Completed |
NCT02260544 -
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
|
Phase 1 | |
| Completed |
NCT01735071 -
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01611766 -
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
|
Phase 3 | |
| Completed |
NCT02735928 -
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor
|
N/A | |
| Completed |
NCT02014337 -
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT01376752 -
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
|
Phase 3 |